Edition:
United Kingdom

Shionogi & Co Ltd (4507.T)

4507.T on Tokyo Stock Exchange

7,410JPY
18 Oct 2018
Change (% chg)

¥-152 (-2.01%)
Prev Close
¥7,562
Open
¥7,585
Day's High
¥7,586
Day's Low
¥7,386
Volume
1,451,800
Avg. Vol
1,292,833
52-wk High
¥7,739
52-wk Low
¥5,200

Chart for

About

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company, mainly engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The Company mainly provides its products and services in Japan, Europe and North America markets.

Overall

Beta: 0.99
Market Cap(Mil.): ¥2,061,380.00
Shares Outstanding(Mil.): 329.14
Dividend: 38.00
Yield (%): 1.15

Financials

  4507.T Industry Sector
P/E (TTM): 23.39 30.92 33.69
EPS (TTM): 267.76 -- --
ROI: 15.40 14.76 14.30
ROE: 17.05 16.26 16.03

FDA approves blood disorder drug made by Japan's Shionogi

The U.S. Food and Drug Administration on Tuesday approved Japan-based Shionogi & Co Ltd's treatment for low blood-platelet count or thrombocytopenia in patients with chronic liver disease.

31 Jul 2018

U.S. FDA approves blood disorder drug made by Japan's Shionogi

July 31 The U.S. Food and Drug Administration on Tuesday approved Japan-based Shionogi & Co Ltd's treatment for low blood-platelet count or thrombocytopenia in patients with chronic liver disease.

31 Jul 2018

Earnings vs. Estimates